Conversely, in T2DM, insulin resistance or oxidative stress contributes to BM dysfunction by impairing insulin signaling in podocytes, resulting in structural damage, proteinuria, and glomerulosclerosis, which exacerbates DN and the progression of chronic kidney disease. This evidence concerns the gene INS and glomerulosclerosis.